UBIO Stock - ProShares UltraPro Nasdaq Biotechnology
Unlock GoAI Insights for UBIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Earnings History & Surprises
UBIOLatest News
Frequently Asked Questions about UBIO
What is UBIO's current stock price?
What is the analyst price target for UBIO?
What sector is ProShares UltraPro Nasdaq Biotechnology in?
What is UBIO's market cap?
Does UBIO pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to UBIO for comparison